The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Serum Cholesterol, Blood Pressure, Cigarette Smoking, and Death From Coronary Heart Disease Overall Findings and Differences by Age for 316099 White Men
Abstract
To assess the combined influence of blood pressure (BP), serum cholesterol level, and cigarette smoking on death from coronary heart disease (CHD) and to describe how these associations vary with age, data on those factors and on mortality for 316 099 men screened for the Multiple Risk Factor Intervention Trial (MRFIT) were examined. Vital sta tus of participants has been determined after an average follow-up of 12 years; 6327 deaths from CHD have been identified. Strong graded relationships between serum cho lesterol levels above 4.65 mmol/L (180 mg/dL), systolic BP above 110 mm Hg, and diastolic BP above 70 mm Hg and mortality due to CHD were evident. Smokers with serum cholesterol and systolic BP levels in the highest quintiles had CHD death rates that were approximately 20 times greater than nonsmoking men with systolic BP and cholesterol lev els in the lowest quintile. Systolic and diastolic BP, serum cholesterol level, and cigarettes per day were significant predictors of death due to CHD in all age groups. Systolic BP was a stronger predictor than diastolic BP. These results, together with the findings of clinical trials, offer strong support for intensified preventive efforts in all age groups. (Arch Intern Med. 1992;152:56-64)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Metabolic syndrome is a common additional cardiovascular risk factor in 40% of hypertensive patients.
“metabolic syndrome (40%)”
From 2020 International Society of Hypertension Global Hypertension Practice Guidelines (2020) · cites this paper as [30]
Overweight-obesity is a common additional cardiovascular risk factor in 40% of hypertensive patients.
“overweight-obesity (40%)”
From 2020 International Society of Hypertension Global Hypertension Practice Guidelines (2020) · cites this paper as [30]
Hyperuricemia is a common additional cardiovascular risk factor in 25% of hypertensive patients.
“hyperuricemia (25%)”
From 2020 International Society of Hypertension Global Hypertension Practice Guidelines (2020) · cites this paper as [30]
Lipid disorders (elevated LDL-C and triglycerides) are a common additional cardiovascular risk factor in 30% of hypertensive patients.
“lipid disorders (elevated low-density lipoprotein-cholesterol [LDL-C] and triglycerides [30%])”
From 2020 International Society of Hypertension Global Hypertension Practice Guidelines (2020) · cites this paper as [30]
Diabetes is a common additional cardiovascular risk factor in 15%-20% of hypertensive patients.
“diabetes (15%-20%)”
From 2020 International Society of Hypertension Global Hypertension Practice Guidelines (2020) · cites this paper as [30]
Unhealthy lifestyle habits (eg, smoking, high alcohol intake, sedentary lifestyle) are common additional cardiovascular risk factors in hypertensive patients.
“as well as unhealthy lifestyle habits (eg, smoking, high alcohol intake, sedentary lifestyle). 28-30”
From 2020 International Society of Hypertension Global Hypertension Practice Guidelines (2020) · cites this paper as [30]
Citations
Cites
Statistical methods for rates and proportions
Fleiss, J., Levin, B., & Paik, M. (1973) · Biometrics · doi:10.2307/2529186 · Cited by 21,632
Blood pressure, stroke, and coronary heart disease
Collins, R., Peto, R., MacMahon, S., Godwin, J., Qizilbash, N., Collins, R., MacMahon, S., Hebert, P., Eberlein, K. A., Taylor, J. O., et al. (1990) · The Lancet · doi:10.1016/0140-6736(90)90944-z · Cited by 4,491
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
Frick, M. H., Elo, O., Haapa, K., Heinonen, O. P., Heinsalmi, P., Helo, P., Huttunen, J. K., Kaitaniemi, P., Koskinen, P., Manninen, V., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711123172001 · Cited by 3,881
Anderson, K. M. (1987) · JAMA · doi:10.1001/jama.257.16.2176 · Cited by 1,071
Oliver, M., Heady, J., Morris, J. N., Cooper, J., Geizerova, H., Gyárfás, I., Green, K., Strasser, T., Macfie, W. G., Scott, E., et al. (1978) · Heart · doi:10.1136/hrt.40.10.1069 · Cited by 1,047
EFFECT OF DIET AND SMOKING INTERVENTION ON THE INCIDENCE OF CORONARY HEART DISEASE
Hjermann, I., Holme, I., Byre, K. V., & Leren, P. (1981) · The Lancet · doi:10.1016/s0140-6736(81)91338-6 · Cited by 1,045
Covariate Measurement Errors and Parameter Estimation in a Failure Time Regression Model
Prentice, R. L. (1982) · Biometrika · doi:10.1093/biomet/69.2.331 · Cited by 672
Smoking in relation to the death rates of one million men and women.
Ec, H. (1966) · PubMed · Cited by 648
Ischemic Heart Disease, Atherosclerosis, and Longevity
Gofman, J. W., Young, W., & Tandy, R. K. (1966) · Circulation · doi:10.1161/01.cir.34.4.679 · Cited by 587
Kannel, W. B., Neaton, J. D., Wentworth, D. N., Thomas, H. E., Stamler, J., Hulley, S. B., & Kjelsberg, M. O. (1986) · American Heart Journal · doi:10.1016/0002-8703(86)90481-3 · Cited by 502
Self-citationFarnett, L. (1991) · JAMA · doi:10.1001/jama.265.4.489 · Cited by 417
A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate.
Miettinen, M., Turpeinen, O., & Karvonen, M. J. (1979) · Heart · doi:10.1136/hrt.42.3.370 · Cited by 364
Rutan, G. H., Kuller, L. H., Neaton, J. D., Wentworth, D. N., McDonald, R. H., & Smith, W. M. (1988) · Circulation · doi:10.1161/01.cir.77.3.504 · Cited by 308
Self-citationBlood pressure (systolic and diastolic) and risk of fatal coronary heart disease.
Stamler, J., Neaton, J. D., & Wentworth, D. N. (1989) · Hypertension · doi:10.1161/01.hyp.13.5_suppl.i2 · Cited by 283
Self-citationCoronary Heart Disease, Stroke, and Aortic Aneurysm
Hammond, E., & Garfinkel, L. (1969) · Archives of Environmental Health An International Journal · doi:10.1080/00039896.1969.10666825 · Cited by 274
Neaton, J. D., Kuller, L. H., Wentworth, D. N., & Borhani, N. O. (1984) · American Heart Journal · doi:10.1016/0002-8703(84)90669-0 · Cited by 258
Self-citationPredicting coronary heart disease in middle-aged and older persons. The Framington study
Gordon, T. (1977) · JAMA · doi:10.1001/jama.238.6.497 · Cited by 239
Wentworth, D. N., Neaton, J. D., & Rasmussen, W. L. (1983) · American Journal of Public Health · doi:10.2105/ajph.73.11.1270 · Cited by 225
Self-citationThe interrelationship of serum cholesterol, hypertension, body weight, and risk of coronary disease
Chapman, J. M., & Massey, F. J. (1964) · Journal of Chronic Diseases · doi:10.1016/0021-9681(64)90163-8 · Cited by 215
Is Elevated Serum Cholesterol Level a Risk Factor for Coronary Heart Disease in the Elderly?
Benfante, R. (1990) · JAMA · doi:10.1001/jama.1990.03440030080025 · Cited by 211
The multiple risk factor intervention trial (MRFIT) II. The development of the protocol.
Sherwin, R., Kaelber, C., Kezdi, P., Kjelsberg, M. O., & Thomas, H. (1981) · Preventive Medicine · doi:10.1016/0091-7435(81)90058-x · Cited by 188
Rose, G., & Shipley, M. J. (1986) · BMJ · doi:10.1136/bmj.293.6542.306 · Cited by 170
High Blood Cholesterol in Elderly Men and the Excess Risk for Coronary Heart Disease
Rubin, S. M., Sidney, S., Black, D. M., Browner, W. S., Hulley, S. B., & Cummings, S. R. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-12-916 · Cited by 152
Ischemic heart disease risk factors after age 50
Barrett-Connor, E. L., Suarez, L., Khaw, K., Criqui, M. H., & Wingard, D. L. (1984) · Journal of Chronic Diseases · doi:10.1016/0021-9681(84)90066-3 · Cited by 142
A random-walk model of human mortality and aging
Woodbury, M. A., & Mantón, K. G. (1977) · Theoretical Population Biology · doi:10.1016/0040-5809(77)90005-3 · Cited by 134
Risk factors in middle age that predict early and late onset of coronary heart disease
Benfante, R., REED, D. M., MacLean, C. J., & Yano, K. (1989) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(89)90082-6 · Cited by 70
Sorlie, P. D., & Gold, E. B. (1987) · American Journal of Public Health · doi:10.2105/ajph.77.2.148 · Cited by 70
Psaty, B. M., Koepsell, T. D., Manolio, T. A., Longstreth, W. T., Jr., Wagner, E. H., WAHL, P. W., & Kronmal, R. A. (1990) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(90)90079-5 · Cited by 61
Dischinger, P. C., & DuChene, A. G. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90164-9 · Cited by 60
Risk factor modification trials: Implications for the elderly
Stamler, J. F. (1988) · European Heart Journal · doi:10.1093/eurheartj/9.suppl_d.9 · Cited by 38
Are risk factors for chd the same at different ages
Kuller, L. H. (1989) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(89)90081-4 · Cited by 21
Canner, P. L., & Halperin, M. (1981) · Circulation · doi:10.1161/01.cir.63.6.1342 · Cited by 20
Stamler, J., Neaton, J. D., Wentworth, D. N., Shih, J., Dyer, A. R., Shekelle, R. B., & Stamler, R. (1992) · Medical science symposia series · doi:10.1007/978-94-011-2700-4_3 · Cited by 7
Self-citationCornfield, J., & Detre, K. M. (1979) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112852 · Cited by 6
Flagged first, then by citations
Cited by
Sorted by citations
2020 International Society of Hypertension Global Hypertension Practice Guidelines
Unger, T., Borghi, C., Charchar, F., Khan, N. A., Poulter, N. R., Prabhakaran, D., Ramirez, A., Schlaich, M., Stergiou, G. S., Tomaszewski, M., et al. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15026 · Cited by 4,132
Pickering, T. G., Hall, J. E., Appel, L. J., Falkner, B. E., Graves, J., Hill, M. N., Jones, D. W., Kurtz, T., Sheps, S. G., & Roccella, E. J. (2005) · Circulation · doi:10.1161/01.cir.0000154900.76284.f6 · Cited by 3,985
Pickering, T. G., Hall, J. E., Appel, L. J., Falkner, B. E., Graves, J., Hill, M. N., Jones, D. W., Kurtz, T., Sheps, S. G., & Roccella, E. J. (2005) · Hypertension · doi:10.1161/01.hyp.0000150859.47929.8e · Cited by 2,051
Longitudinal tracking of adolescent smoking, physical activity, and food choice behaviors
Kelder, S. H., Perry, C. L., Klepp, K. I., & Lytle, L. L. (1994) · American Journal of Public Health · doi:10.2105/ajph.84.7.1121 · Cited by 1,388
2020 International Society of Hypertension global hypertension practice guidelines
Unger, T., Borghi, C., Charchar, F., Khan, N. A., Poulter, N. R., Prabhakaran, D., Ramirez, A., Schlaich, M., Stergiou, G. S., Tomaszewski, M., et al. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002453 · Cited by 1,283
Jousilahti, P., Vartiainen, E., Tuomilehto, J., & Puska, P. (1999) · Circulation · doi:10.1161/01.cir.99.9.1165 · Cited by 890
Estimates of global and regional potential health gains from reducing multiple major risk factors
Ezzati, M., Vander Hoorn, S., Rodgers, A., Lopez, A. D., Mathers, C. D., & Murray, C. J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13968-2 · Cited by 610
Predictors of Adherence With Antihypertensive and Lipid-Lowering Therapy
Chapman, R. H. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.10.1147 · Cited by 506
Kokkinos, P. F., Narayan, P., Colleran, J. A., Pittaras, A., Notargiacomo, A., Reda, D., & Papademetriou, V. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511303332204 · Cited by 354
Blood glucose and risk of cardiovascular disease in the Asia Pacific region.
Asia Pacific Cohort Studies Collaboration (2004) · Diabetes Care · doi:10.2337/diacare.27.12.2836 · Cited by 302
Coffee Consumption and Serum Lipids: A Meta-Analysis of Randomized Controlled Clinical Trials
Jee, S. H., He, J., Appel, L. J., Whelton, P. K., Suh, II, & Klag, M. J. (2001) · American Journal of Epidemiology · doi:10.1093/aje/153.4.353 · Cited by 301
Tamhane, S., Rodriguez-Gutierrez, R., Iqbal, A. M., Prokop, L. J., Bancos, I., Speiser, P. W., & Murad, M. H. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01862 · Cited by 123
Law, M. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/72.5.1291s · Cited by 115
Zhao, J., Leung, J. Y. Y., Lin, S. L., & Mary Schooling, C. (2016) · Preventive Medicine · doi:10.1016/j.ypmed.2015.12.021 · Cited by 101
Satoh, M., Ohkubo, T., Asayama, K., Murakami, Y., Sakurai, M., Nakagawa, H., Iso, H., Okayama, A., Miura, K., Imai, Y., et al. (2015) · Hypertension · doi:10.1161/hypertensionaha.114.04639 · Cited by 54
wakugami, K., Iseki, K., Kimura, Y., Okumura, K., lkemiya, Y., Muratani, H., & Fukiyama, K. (1998) · Japanese Circulation Journal · doi:10.1253/jcj.62.7 · Cited by 51
Bhargava, A. (2003) · Population Health Metrics · doi:10.1186/1478-7954-1-3 · Cited by 50
Young, S., Veniant, M., Beigneux, A., Bensadoun, A., & Fong, L. (2008) · Current Drug Targets · doi:10.2174/138945008783755629 · Cited by 33
Sasaki, J., Kita, T., Mabuchi, H., Matsuzaki, M., Matsuzawa, Y., Nakaya, N., Oikawa, S., Saito, Y., Shimamoto, K., Kono, S., et al. (2006) · Circulation Journal · doi:10.1253/circj.70.810 · Cited by 32
Tsukinoki, R., Okamura, T., Watanabe, M., Kokubo, Y., Higashiyama, A., Nishimura, K., Takegami, M., Murakami, Y., Okayama, A., & Miyamoto, Y. (2014) · American Journal of Hypertension · doi:10.1093/ajh/hpu059 · Cited by 27
Liao, P.-C., Chen, M.-S., Jhou, M.-J., Chen, T.-C., Yang, C.-T., & Lu, C.-J. (2022) · Diagnostics · doi:10.3390/diagnostics12081965 · Cited by 21
Metadata
- Authors
- Neaton, J. D.
- Corresponding author
- Neaton, James D.
- ORCID
- Neaton, James D.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 1992-01-01
- Volume
- 152
- Issue
- 1
- Pages
- 56
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W1995779077
- Cited by
- 784
- References
- 37
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 3 · 2023: 13 · 2022: 11 · 2021: 7 · 2020: 17 · 2019: 7 · 2018: 13 · 2017: 15 · 2016: 23 · 2015: 16 · 2014: 30 · 2013: 19 · 2012: 23
- FWCI
- 16.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Archives of Internal Medicine (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (1-RO1-HL-28715)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- coronary heart disease mortality, serum cholesterol, blood pressure, cigarette smoking, age differences, systolic blood pressure, cardiovascular risk factors, Multiple Risk Factor Intervention Trial, white men
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review